153 related articles for article (PubMed ID: 204955)
1. Combined use of local irradiation and Corynebacterium parvum in the treatment of the murine line 1 lung carcinoma.
Ullrich RL; Adams LM
Radiat Res; 1978 Feb; 73(2):267-73. PubMed ID: 204955
[No Abstract] [Full Text] [Related]
2. Local control and disease-free survival after treatment of a squamous cell carcinoma by Corynebacterium parvum and local irradiation.
Suit HD; Sedlacek R; Silobrcic V
Cancer Res; 1977 Nov; 37(11):3869-75. PubMed ID: 908026
[No Abstract] [Full Text] [Related]
3. Responsiveness of senescent mice to the antitumor properties of Corynebacterium parvum.
Yuhas JM; Ullrich RL
Cancer Res; 1976 Jan; 36(1):161-6. PubMed ID: 1247995
[TBL] [Abstract][Full Text] [Related]
4. Effect of Corynebacterium parvum on the response to irradiation of a C3H fibrosarcoma.
Suit HD; Sedlacek R; Wagner M; Orsi L; Silobrcic V; Rothman KJ
Cancer Res; 1976 Apr; 36(4):1305-14. PubMed ID: 1260756
[TBL] [Abstract][Full Text] [Related]
5. Corynebacterium parvum and cyclophosphamide as combination treatment for a murine mammary adenocarcinoma.
Purnell DM; Bartlett GL; Kreider JW; Biro TG
Cancer Res; 1977 Apr; 37(4):1137-40. PubMed ID: 844041
[TBL] [Abstract][Full Text] [Related]
6. Specific and nonspecific stimulation of resistance to the growth and metastasis of the line 1 lung carcinoma.
Yuhas JM; Toya RE; Wagner E
Cancer Res; 1975 Jan; 35(1):242-4. PubMed ID: 1109793
[TBL] [Abstract][Full Text] [Related]
7. Proceedings: Treatment of a metastasizing murine tumour with Corynebacterium parvum.
Sadler TE; Castro JE
Br J Cancer; 1975 Feb; 31(2):264. PubMed ID: 1164486
[No Abstract] [Full Text] [Related]
8. Antitumor activity of Corynebacterium parvum and retinyl palmitate used in combination on the Lewis lung carcinoma.
Pavelic ZP; Dave S; Bialkowski S; Priore RL; Greco WR
Cancer Res; 1980 Dec; 40(12):4617-21. PubMed ID: 7438095
[TBL] [Abstract][Full Text] [Related]
9. Surgery plus Corynebacterium parvum immunotherapy for Lewis lung carcinoma in mice.
Karrer K; Rella W; Goldin A
Eur J Cancer (1965); 1979 Jun; 15(6):867-73. PubMed ID: 499275
[No Abstract] [Full Text] [Related]
10. Lasting rejection of mammary adenocarcinoma cell tumors in DBA-2 mice with intratumor injection of killed Corynebacterium parvum.
Likhite VV; Halpern BN
Cancer Res; 1974 Feb; 34(2):341-4. PubMed ID: 4810906
[No Abstract] [Full Text] [Related]
11. Effects of Corynebacterium parvum on tumour metastases in mice.
Castro JE
Br J Surg; 1977 Oct; 64(10):721-4. PubMed ID: 922293
[No Abstract] [Full Text] [Related]
12. Effects and mode of action of Corynebacterium parvum on murine tumour metastases.
Castro JE; Sadler TE; Jones PD
Dev Biol Stand; 1977 Apr 13-15; 38():277-81. PubMed ID: 608510
[TBL] [Abstract][Full Text] [Related]
13. Protection by Corynebacterium parvum against tumour cells injected intravenously.
Milas L; Mujagić H
Rev Eur Etud Clin Biol; 1972 May; 17(5):498-500. PubMed ID: 4648182
[No Abstract] [Full Text] [Related]
14. Active experimental inhibition of cancer by corynebacterium parvum.
Wrba H; Dutter A
Osterr Z Onkol; 1977 Oct; 4(2-3):60-1. PubMed ID: 579449
[TBL] [Abstract][Full Text] [Related]
15. Proceedings: Combined surgery and Corynebacterium parvum for treatment of metastasizing tumour in mice.
Castro JE; Sadler TE
Br J Surg; 1975 Feb; 62(2):156. PubMed ID: 1115892
[No Abstract] [Full Text] [Related]
16. Effect of adriamycin and Corynebacterium parvum in tumor-bearing mice: modulation of response to sheep red blood cells.
Dimitrov NV; Denny TN; Weisman MF; Cameron DG
J Natl Cancer Inst; 1979 Aug; 63(2):423-6. PubMed ID: 379400
[TBL] [Abstract][Full Text] [Related]
17. Effect of glucan and other adjuvants on the clearance of radiolabeled tumor cells from mouse lungs.
Proctor JW; Stiteler RD; Yamamura Y; Mansell PW; Winters R
Cancer Treat Rep; 1978 Nov; 62(11):1873-80. PubMed ID: 728905
[TBL] [Abstract][Full Text] [Related]
18. Effects of dose and schedule of immune stimulant on efficacy of combination Corynebacterium parvum-cyclophosphamide treatment for a murine mammary adenocarcinoma.
Purnell DM; Bartlett GL; Kreider JW
Cancer Res; 1979 Jan; 39(1):1-5. PubMed ID: 761179
[TBL] [Abstract][Full Text] [Related]
19. Development of concomitant immunity in mice bearing the weakly immunogenic line 1 lung carcinoma.
Yuhas JM; Pazmiño NH; Wagner E
Cancer Res; 1975 Jan; 35(1):237-41. PubMed ID: 162863
[TBL] [Abstract][Full Text] [Related]
20. Effect of the combination of Corynebacterium parvum and levamisole on murine tumors.
Anaclerio A; Conti G; Moras ML; Barale C; Spreafico F
Eur J Cancer (1965); 1977 Dec; 13(12):1451-53. PubMed ID: 413718
[No Abstract] [Full Text] [Related]
[Next] [New Search]
